Global Cysticercosis Treatment Market Growth (Status and Outlook) 2018-2023
Published On: October 2018
 
Report ID:352741
 
 
Pages: 116




Cysticercosis or Taeniasis is an infection caused primarily due to tapeworms.

Globally, increasing government initiative to eradicate Cysticercosis, rise in the in incidences of Cysticercosis in developing regions, and increasing awareness among people for Cysticercosis are the prime growth drivers of global cysticercosis treatment market.

Over the next five years, LPI(LP Information) projects that Cysticercosis Treatment will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Cysticercosis Treatment market for 2018-2023.

This report presents a comprehensive overview, market shares and growth opportunities of Cysticercosis Treatment market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:

Praziquantel

Albendazole

Segmentation by application:

Hospitals and Clinics

Others

We can also provide the customized separate regional or country-level reports, for the following regions:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Spain

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

GlaxoSmithKline

Amedra Pharmaceuticals

Bayer

Klarsehen India

Ranbaxy

Salius

Cipla

Pharmaco-Kinesis

Bonaide

Taj Pharmaceuticals

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Cysticercosis Treatment market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

To understand the structure of Cysticercosis Treatment market by identifying its various subsegments.

Focuses on the key global Cysticercosis Treatment players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Cysticercosis Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the size of Cysticercosis Treatment submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Contents

2018-2023 Global Cysticercosis Treatment Market Report (Status and Outlook)

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Economic Indicators

1.6 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Cysticercosis Treatment Market Size 2013-2023

2.1.2 Cysticercosis Treatment Market Size CAGR by Region

2.2 Cysticercosis Treatment Segment by Type

2.2.1 Praziquantel

2.2.2 Albendazole

2.3 Cysticercosis Treatment Market Size by Type

2.3.1 Global Cysticercosis Treatment Market Size Market Share by Type (2013-2018)

2.3.2 Global Cysticercosis Treatment Market Size Growth Rate by Type (2013-2018)

2.4 Cysticercosis Treatment Segment by Application

2.4.1 Hospitals and Clinics

2.4.2 Others

2.5 Cysticercosis Treatment Market Size by Application

2.5.1 Global Cysticercosis Treatment Market Size Market Share by Application (2013-2018)

2.5.2 Global Cysticercosis Treatment Market Size Growth Rate by Application (2013-2018)

3 Global Cysticercosis Treatment by Players

3.1 Global Cysticercosis Treatment Market Size Market Share by Players

3.1.1 Global Cysticercosis Treatment Market Size by Players (2016-2018)

3.1.2 Global Cysticercosis Treatment Market Size Market Share by Players (2016-2018)

3.2 Global Cysticercosis Treatment Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Cysticercosis Treatment by Regions

4.1 Cysticercosis Treatment Market Size by Regions

4.2 Americas Cysticercosis Treatment Market Size Growth

4.3 APAC Cysticercosis Treatment Market Size Growth

4.4 Europe Cysticercosis Treatment Market Size Growth

4.5 Middle East & Africa Cysticercosis Treatment Market Size Growth

5 Americas

5.1 Americas Cysticercosis Treatment Market Size by Countries

5.2 Americas Cysticercosis Treatment Market Size by Type

5.3 Americas Cysticercosis Treatment Market Size by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Cysticercosis Treatment Market Size by Countries

6.2 APAC Cysticercosis Treatment Market Size by Type

6.3 APAC Cysticercosis Treatment Market Size by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Countries

7 Europe

7.1 Europe Cysticercosis Treatment by Countries

7.2 Europe Cysticercosis Treatment Market Size by Type

7.3 Europe Cysticercosis Treatment Market Size by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Spain

7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Cysticercosis Treatment by Countries

8.2 Middle East & Africa Cysticercosis Treatment Market Size by Type

8.3 Middle East & Africa Cysticercosis Treatment Market Size by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Cysticercosis Treatment Market Forecast

10.1 Global Cysticercosis Treatment Market Size Forecast (2018-2023)

10.2 Global Cysticercosis Treatment Forecast by Regions

10.2.1 Global Cysticercosis Treatment Forecast by Regions (2018-2023)

10.2.2 Americas Market Forecast

10.2.3 APAC Market Forecast

10.2.4 Europe Market Forecast

10.2.5 Middle East & Africa Market Forecast

10.3 Americas Forecast by Countries

10.3.1 United States Market Forecast

10.3.2 Canada Market Forecast

10.3.3 Mexico Market Forecast

10.3.4 Brazil Market Forecast

10.4 APAC Forecast by Countries

10.4.1 China Market Forecast

10.4.2 Japan Market Forecast

10.4.3 Korea Market Forecast

10.4.4 Southeast Asia Market Forecast

10.4.5 India Market Forecast

10.4.6 Australia Market Forecast

10.5 Europe Forecast by Countries

10.5.1 Germany Market Forecast

10.5.2 France Market Forecast

10.5.3 UK Market Forecast

10.5.4 Italy Market Forecast

10.5.5 Russia Market Forecast

10.5.6 Spain Market Forecast

10.6 Middle East & Africa Forecast by Countries

10.6.1 Egypt Market Forecast

10.6.2 South Africa Market Forecast

10.6.3 Israel Market Forecast

10.6.4 Turkey Market Forecast

10.6.5 GCC Countries Market Forecast

10.7 Global Cysticercosis Treatment Forecast by Type

10.8 Global Cysticercosis Treatment Forecast by Application

11 Key Players Analysis

11.1 GlaxoSmithKline

11.1.1 Company Details

11.1.2 Cysticercosis Treatment Product Offered

11.1.3 GlaxoSmithKline Cysticercosis Treatment Revenue, Gross Margin and Market Share (2016-2018)

11.1.4 Main Business Overview

11.1.5 GlaxoSmithKline News

11.2 Amedra Pharmaceuticals

11.2.1 Company Details

11.2.2 Cysticercosis Treatment Product Offered

11.2.3 Amedra Pharmaceuticals Cysticercosis Treatment Revenue, Gross Margin and Market Share (2016-2018)

11.2.4 Main Business Overview

11.2.5 Amedra Pharmaceuticals News

11.3 Bayer

11.3.1 Company Details

11.3.2 Cysticercosis Treatment Product Offered

11.3.3 Bayer Cysticercosis Treatment Revenue, Gross Margin and Market Share (2016-2018)

11.3.4 Main Business Overview

11.3.5 Bayer News

11.4 Klarsehen India

11.4.1 Company Details

11.4.2 Cysticercosis Treatment Product Offered

11.4.3 Klarsehen India Cysticercosis Treatment Revenue, Gross Margin and Market Share (2016-2018)

11.4.4 Main Business Overview

11.4.5 Klarsehen India News

11.5 Ranbaxy

11.5.1 Company Details

11.5.2 Cysticercosis Treatment Product Offered

11.5.3 Ranbaxy Cysticercosis Treatment Revenue, Gross Margin and Market Share (2016-2018)

11.5.4 Main Business Overview

11.5.5 Ranbaxy News

11.6 Salius

11.6.1 Company Details

11.6.2 Cysticercosis Treatment Product Offered

11.6.3 Salius Cysticercosis Treatment Revenue, Gross Margin and Market Share (2016-2018)

11.6.4 Main Business Overview

11.6.5 Salius News

11.7 Cipla

11.7.1 Company Details

11.7.2 Cysticercosis Treatment Product Offered

11.7.3 Cipla Cysticercosis Treatment Revenue, Gross Margin and Market Share (2016-2018)

11.7.4 Main Business Overview

11.7.5 Cipla News

11.8 Pharmaco-Kinesis

11.8.1 Company Details

11.8.2 Cysticercosis Treatment Product Offered

11.8.3 Pharmaco-Kinesis Cysticercosis Treatment Revenue, Gross Margin and Market Share (2016-2018)

11.8.4 Main Business Overview

11.8.5 Pharmaco-Kinesis News

11.9 Bonaide

11.9.1 Company Details

11.9.2 Cysticercosis Treatment Product Offered

11.9.3 Bonaide Cysticercosis Treatment Revenue, Gross Margin and Market Share (2016-2018)

11.9.4 Main Business Overview

11.9.5 Bonaide News

11.10 Taj Pharmaceuticals

11.10.1 Company Details

11.10.2 Cysticercosis Treatment Product Offered

11.10.3 Taj Pharmaceuticals Cysticercosis Treatment Revenue, Gross Margin and Market Share (2016-2018)

11.10.4 Main Business Overview

11.10.5 Taj Pharmaceuticals News

12 Research Findings and Conclusion




Please fill the form below, to recieve the report sample

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*

Please fill the form below for enquiry

Name*
Email*
Phone*
Name of the Company*
Title / Designation*
Country*
Your specific requirements*
Human Verification*
   Our Clients
  • \
   Payment Mode



For More Information

   For More Information

If you have any query? Please contact us

sales@fiormarkets.com
+1-201-465-4211


Copyright © 2019 Fior Market Research LLP, All Rights Reserved.